miRNA-Processing Gene Methylation and Cancer Risk
- PMID: 29475968
- PMCID: PMC5932226
- DOI: 10.1158/1055-9965.EPI-17-0849
miRNA-Processing Gene Methylation and Cancer Risk
Abstract
Background: Dysregulation of miRNA and methylation levels are epigenetic hallmarks of cancer, potentially linked via miRNA-processing genes. Studies have found genetic alterations to miRNA-processing genes in cancer cells and human population studies. Our objective was to prospectively examine changes in DNA methylation of miRNA-processing genes and their associations with cancer risk.Methods: We examined cohort data from the Department of Veterans' Affairs Normative Aging Study. Participants were assessed every 3 to 5 years starting in 1999 through 2013 including questionnaires, medical record review, and blood collection. Blood from 686 consenting participants was analyzed using the Illumina 450K BeadChip array to measure methylation at CpG sites throughout the genome. We selected 19 genes based on a literature review, with 519 corresponding CpG sites. We then used Cox proportional hazards models to examine associations with cancer incidence, and generalized estimating equations to examine associations with cancer prevalence. Associations at false discovery rate < 0.05 were considered statistically significant.Results: Methylation of three CpGs (DROSHA: cg23230564, TNRC6B: cg06751583, and TNRC6B: cg21034183) was prospectively associated with time to cancer development (positively for cg06751583, inversely for cg23230564 and cg21034183), whereas methylation of one CpG site (DROSHA: cg16131300) was positively associated with cancer prevalence.Conclusions: DNA methylation of DROSHA, a key miRNA-processing gene, and TNRC6B may play a role in early carcinogenesis.Impact: Changes in miRNA processing may exert multiple effects on cancer development, including protecting against it via altered global miRNAs, and may be a useful early detection biomarker of cancer. Cancer Epidemiol Biomarkers Prev; 27(5); 550-7. ©2018 AACR.
©2018 American Association for Cancer Research.
Conflict of interest statement
The authors have no conflicts of interest to report.
Figures
Similar articles
-
DNA Methylation of Telomere-Related Genes and Cancer Risk.Cancer Prev Res (Phila). 2018 Aug;11(8):511-522. doi: 10.1158/1940-6207.CAPR-17-0413. Epub 2018 Jun 12. Cancer Prev Res (Phila). 2018. PMID: 29895583 Free PMC article.
-
Longitudinal Study of DNA Methylation of Inflammatory Genes and Cancer Risk.Cancer Epidemiol Biomarkers Prev. 2015 Oct;24(10):1531-8. doi: 10.1158/1055-9965.EPI-15-0198. Epub 2015 Aug 11. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 26265203 Free PMC article.
-
Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.Mol Med Rep. 2018 Nov;18(5):4446-4456. doi: 10.3892/mmr.2018.9441. Epub 2018 Sep 3. Mol Med Rep. 2018. PMID: 30221710 Free PMC article.
-
Methylation of miRNA genes and oncogenesis.Biochemistry (Mosc). 2015 Feb;80(2):145-62. doi: 10.1134/S0006297915020029. Biochemistry (Mosc). 2015. PMID: 25756530 Review.
-
Epigenetic regulation of microRNAs in cancer: an integrated review of literature.Mutat Res. 2011 Dec 1;717(1-2):77-84. doi: 10.1016/j.mrfmmm.2011.03.008. Epub 2011 Mar 21. Mutat Res. 2011. PMID: 21420983 Review.
Cited by
-
The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC).Heliyon. 2024 Sep 27;10(19):e38663. doi: 10.1016/j.heliyon.2024.e38663. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39403460 Free PMC article. Review.
-
Crosstalk between miRNAs and DNA Methylation in Cancer.Genes (Basel). 2023 May 12;14(5):1075. doi: 10.3390/genes14051075. Genes (Basel). 2023. PMID: 37239435 Free PMC article. Review.
-
MicroRNAs and long non-coding RNAs in cartilage homeostasis and osteoarthritis.Front Cell Dev Biol. 2022 Dec 13;10:1092776. doi: 10.3389/fcell.2022.1092776. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36582467 Free PMC article. Review.
-
Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer.J Cancer Res Clin Oncol. 2023 Aug;149(9):5687-5696. doi: 10.1007/s00432-022-04525-w. Epub 2022 Dec 21. J Cancer Res Clin Oncol. 2023. PMID: 36542159 Free PMC article.
-
Stem-Cell Theory of Cancer: Implications for Antiaging and Anticancer Strategies.Cancers (Basel). 2022 Mar 4;14(5):1338. doi: 10.3390/cancers14051338. Cancers (Basel). 2022. PMID: 35267646 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources